The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Faron have extra company meeting 7.7.2022.and then they decide to have share issue with 11 million new shares.
We dont know who buy that shares is shareholders or outside buyers that Markku and his colleges will decide.
-I hope that shareholders get chance this time....
https://www.swedbank-aktiellt.se/analyser/2022/03/28/faron_pharmaceuticals.csp
Lago buy on 235 and sell on 225.
Then Lago is selling or buying the amount in Nazz.
Goldman seems to have a big buy order in Nazz,
for many weeks they have been active with small numbers every day.-Hope that some news is coming about Bex soon!Good Ones!
By the way goldman put in a buy order of +67000 shares on price 2,78 euro last minutes in Naz friday.
That many buy shares Goldman dont get under 3 euro.
Maybe it it is a tactic buy but we will see on Monday are they continue buying.
Luck,
Let us hope that trials give successful information for Bex and for the others too.
When big pharma wants Bex then is the question who is paying highest.
This is a big lotto for us shareholders because trials can be pancake too.
Bid will be under 5€/share if Goldman have something to do with it.
-Why try to get share price down otherwise?
Right price in this moment when trials are not done maybe 10 euro/share and much more if trials are good.